Tailored Nanovaccines Stimulate Neoantigen-Specific T-Cell Responses in Melanoma Patient Cells
An ex vivo study shows tailored PEI-PLGA nanovaccines functionalized with poly(I:C) enhanced neoantigen-specific T-cell activation in cells from melanoma patients.
